Role of extended #cvCoag in unprovoked #VTE. https://t.co/6AlMcuo46d
Great Debates in Vascular Medicine: Extended duration anticoagulation for unprovoked venous thromboembolism – Coming to consensus when the debate rages on https://t.co/d9EkDK8oNX
RT @YogenKanthi: The principles of this debate still hold water-understanding transient or persistent risk factors in #DVT can help in mana…
Do you like a good debate? Read two perspectives on the role of extended #cvCoag in unprovoked #VTE from these @VMJ_SVM thought leaders: https://t.co/yNnqfmyoqt @YogenKanthi
RT @VMJ_SVM: Patients with unprovoked #VTE, should they get extended #cvCoag therapy? See how two experts weigh in. https://t.co/yNnqfmyoqt…
RT @VMJ_SVM: Patients with unprovoked #VTE, should they get extended #cvCoag therapy? See how two experts weigh in. https://t.co/yNnqfmyoqt…
RT @VMJ_SVM: Patients with unprovoked #VTE, should they get extended #cvCoag therapy? See how two experts weigh in. https://t.co/yNnqfmyoqt…
RT @VMJ_SVM: Patients with unprovoked #VTE, should they get extended #cvCoag therapy? See how two experts weigh in. https://t.co/yNnqfmyoqt…
RT @VMJ_SVM: Patients with unprovoked #VTE, should they get extended #cvCoag therapy? See how two experts weigh in. https://t.co/yNnqfmyoqt…
RT @VMJ_SVM: Patients with unprovoked #VTE, should they get extended #cvCoag therapy? See how two experts weigh in. https://t.co/yNnqfmyoqt…
RT @VMJ_SVM: Patients with unprovoked #VTE, should they get extended #cvCoag therapy? See how two experts weigh in. https://t.co/yNnqfmyoqt…
RT @VMJ_SVM: Patients with unprovoked #VTE, should they get extended #cvCoag therapy? See how two experts weigh in. https://t.co/yNnqfmyoqt…
RT @VMJ_SVM: Patients with unprovoked #VTE, should they get extended #cvCoag therapy? See how two experts weigh in. https://t.co/yNnqfmyoqt…
RT @VMJ_SVM: Patients with unprovoked #VTE, should they get extended #cvCoag therapy? See how two experts weigh in. https://t.co/yNnqfmyoqt…
RT @VMJ_SVM: Patients with unprovoked #VTE, should they get extended #cvCoag therapy? See how two experts weigh in. https://t.co/yNnqfmyoqt…
Patients with unprovoked #VTE, should they get extended #cvCoag therapy? See how two experts weigh in. https://t.co/yNnqfmyoqt @YogenKanthi
RT @Angiologist: "Lifelong" anticoagulation after unprovoked clot, right? WAIT, says @YogenKanthi in @VMJ_SVM and totally makes you think!…
RT @VMJ_SVM: Our Aug 2018 issue includes a "Great Debate" on the role of extended #cvCoag for #VTE from @YogenKanthi and Greg Piazza of @Br…
RT @santamariaparo: Guess we can change the natural history of VTE! https://t.co/yEoIKFc1Ty
RT @Angiologist: "Lifelong" anticoagulation after unprovoked clot, right? WAIT, says @YogenKanthi in @VMJ_SVM and totally makes you think!…
Need to integrate risk of recurrence, risk of bleeding and patient preference when deciding long-term anticoagulation for VTE. #TeamHaem
Guess we can change the natural history of VTE!
RT @VMJ_SVM: Our Aug 2018 issue includes a "Great Debate" on the role of extended #cvCoag for #VTE from @YogenKanthi and Greg Piazza of @Br…
RT @Angiologist: "Lifelong" anticoagulation after unprovoked clot, right? WAIT, says @YogenKanthi in @VMJ_SVM and totally makes you think!…
RT @Angiologist: "Lifelong" anticoagulation after unprovoked clot, right? WAIT, says @YogenKanthi in @VMJ_SVM and totally makes you think!…
RT @Angiologist: "Lifelong" anticoagulation after unprovoked clot, right? WAIT, says @YogenKanthi in @VMJ_SVM and totally makes you think!…
RT @Angiologist: "Lifelong" anticoagulation after unprovoked clot, right? WAIT, says @YogenKanthi in @VMJ_SVM and totally makes you think!…
"Lifelong" anticoagulation after unprovoked clot, right? WAIT, says @YogenKanthi in @VMJ_SVM and totally makes you think! https://t.co/USHmXRvEix #thrombosis #hematology @SVM_tweets https://t.co/A6Do46JDVh
RT @YogenKanthi: I had fun working on this piece with Dr. Greg Piazza @BWHResearch ! @SVM_tweets @heatherlgornik https://t.co/5i1WuHhb9K
I had fun working on this piece with Dr. Greg Piazza @BWHResearch ! @SVM_tweets @heatherlgornik
Our Aug 2018 issue includes a "Great Debate" on the role of extended #cvCoag for #VTE from @YogenKanthi and Greg Piazza of @BrighamWomens https://t.co/bJOqHcrsR7
RT @Echoraljpangio: Great Debates in Vascular Medicine: Extended duration anticoagulation for unprovoked venous thromboembolism – Coming to…
Great Debates in Vascular Medicine: Extended duration anticoagulation for unprovoked venous thromboembolism – Coming to consensus when the debate rages on - Yogendra Kanthi, Gregory Piazza, 2018 https://t.co/vOfVuAA1HA
RT @VMJ_SVM: From the 2017 @SVM_tweets annual meeting, @YogenKanthi and Dr. Piazza summarize the evidence for extended #cvCoag for unprovok…
RT @Echoraljpangio: https://t.co/NAZbzpioaO ANTICOAGULATION DURATION #DVT #ANTICOAGULATION @ClubVasculaire @AJeunesMedVasc @lasfmv https://…
RT @VMJ_SVM: From the 2017 @SVM_tweets annual meeting, @YogenKanthi and Dr. Piazza summarize the evidence for extended #cvCoag for unprovok…
RT @VMJ_SVM: From the 2017 @SVM_tweets annual meeting, @YogenKanthi and Dr. Piazza summarize the evidence for extended #cvCoag for unprovok…
RT @Echoraljpangio: https://t.co/NAZbzpioaO ANTICOAGULATION DURATION #DVT #ANTICOAGULATION @ClubVasculaire @AJeunesMedVasc @lasfmv https://…
RT @Echoraljpangio: https://t.co/NAZbzpioaO ANTICOAGULATION DURATION #DVT #ANTICOAGULATION @ClubVasculaire @AJeunesMedVasc @lasfmv https://…
https://t.co/NAZbzpioaO ANTICOAGULATION DURATION #DVT #ANTICOAGULATION @ClubVasculaire @AJeunesMedVasc @lasfmv https://t.co/0O0mRGmTaY
RT @VMJ_SVM: From the 2017 @SVM_tweets annual meeting, @YogenKanthi and Dr. Piazza summarize the evidence for extended #cvCoag for unprovok…
RT @VMJ_SVM: From the 2017 @SVM_tweets annual meeting, @YogenKanthi and Dr. Piazza summarize the evidence for extended #cvCoag for unprovok…
RT @VMJ_SVM: From the 2017 @SVM_tweets annual meeting, @YogenKanthi and Dr. Piazza summarize the evidence for extended #cvCoag for unprovok…
RT @VMJ_SVM: From the 2017 @SVM_tweets annual meeting, @YogenKanthi and Dr. Piazza summarize the evidence for extended #cvCoag for unprovok…
RT @VMJ_SVM: From the 2017 @SVM_tweets annual meeting, @YogenKanthi and Dr. Piazza summarize the evidence for extended #cvCoag for unprovok…
RT @VMJ_SVM: From the 2017 @SVM_tweets annual meeting, @YogenKanthi and Dr. Piazza summarize the evidence for extended #cvCoag for unprovok…
This was a fun project to work on w Dr. Piazza! https://t.co/mxZ2gtmuCa
From the 2017 @SVM_tweets annual meeting, @YogenKanthi and Dr. Piazza summarize the evidence for extended #cvCoag for unprovoked #VTE in this "Great Debate" article https://t.co/bJOqHcrsR7 https://t.co/rbHEIu1DSM